Results 161 to 170 of about 1,675 (195)
Some of the next articles are maybe not open access.

Epidemiology of PTLD After SOT

2021
PTLD is a relatively rare but important and feared complication of transplantation. Several different types of risk factors (host, infectious, transplant, immunosuppression) are associated with PTLD development. Epstein-Barr virus infection is the single most important risk factor. PTLD is a significant cause of earlier graft loss and added mortality.
openaire   +1 more source

Evolution of PTLD following renal transplantation in a child

Pediatric Transplantation, 2009
Abstract:  We report the case of an eight‐yr‐old child with early onset PTLD half a year after renal transplantation. The patient developed gastrointestinal pain and bowel biopsies revealed imposing lymphoid infiltrates with small spots of lymphoid blasts in the colonic mucosa.
Eva, Markert   +7 more
openaire   +2 more sources

Treatment of PTLD

2010
No therapies are based on data from randomized clinical trials Current outcomes are suboptimal, both in adults and children Death is most common in the first year after diagnosis Success of therapy must include evaluation of allograft outcomes Several new therapies have emerged over the last decade including monoclonal antibody ...
openaire   +1 more source

T‐cell PTLD presenting as acalculous cholecystitis

Pediatric Transplantation, 2008
Abstract:  We report a five‐yr‐old child, presenting three yr after heart transplant with acalculous cholecystitis. Histology revealed EBV negative T‐cell PTLD. The disease involved the gallbladder, liver, lungs, and mesenteric lymph nodes. He was treated with chemotherapy, went into remission, but relapsed after 11 months and died.
Tamir, Miloh   +8 more
openaire   +2 more sources

Isolated pleural PTLD after cardiac transplantation

Cardiovascular Pathology, 2002
PREAMBLE: Epstein-Barr virus infection (EBV) and immunosuppression promote emergence of posttransplant lymphoproliferative disorders (PTLD) in patients undergoing organ transplantation.We report a case of PTLD confined to the pleura.The patient was a 62-year-old male who had undergone cardiac transplant in 1993 for ischemic heart disease.
Manisha, Lamba   +4 more
openaire   +2 more sources

Epidemiology and Prognosis of PTLD After HSCT

2021
PTLD is a relatively rare but important and feared complication of hematopoietic stem cell transplantation (HSCT). Several different types of risk factors (infectious, type of transplant, immunosuppression) are associated with PTLD development after HSCT. Most PTLD cases after HSCT are Epstein-Barr virus positive. Most PTLD cases occur early after HSCT
Vikas R. Dharnidharka, Thomas G. Gross
openaire   +1 more source

Evolving beyond morphology in pediatric PTLD

Blood, 2023
Nader Kim El-Mallawany, Kala Y. Kamdar
openaire   +2 more sources

Recent developments in the pathobiology of PTLD

Pathology, 2014
Post transplant lymphoproliferative disease (PTLD) represents a spectrum of lymphoproliferative processes that may develop in the immunocompromised host following stem cell and solid organ transplantation. PTLD is most commonly of B-cell origin and is associated with the Epstein Barr virus (EBV) in 60–80% of cases.
openaire   +1 more source

Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD

Springer Seminars in Immunopathology, 1998
G, Tosato   +5 more
openaire   +2 more sources

PTLD in liver transplant recipients

Transplantation Proceedings, 2001
M, Rizell, M, Olausson, S, Friman
openaire   +2 more sources

Home - About - Disclaimer - Privacy